Objectives: Endovascular repair of abdominal aortic aneurysms (AAA) has become the treatment of choice in the last decade. Perioperative morbidity and mortality are decreased along with the decreased hospital length of stay and decreased costs. We aimed to evaluate short-term outcomes and to compare conventional outcomes in patients undergoing either endovascular or open transperitoneal surgical repair. Materials and Methods: Totally, 46 consecutive patients presenting with the diagnosis of AAA between October 2012 and February 2014 were prospectively studied. Patients were grouped into two: elective endovascular (n = 24) and elective open repair (n = 22). Perioperative and in-hospital mortality rates, patient demographics, procedural details, postoperative follow-up data were collected. Results: Hospital stay was significantly shorter after endovascular AAA repair (P < 0.01). Endovascular technique was associated with shorter and less invasive perioperative hospital course and fewer postoperative complications. Conclusions: Endovascular repair may be an effective treatment of choice with low mortality and morbidity rates for the patients who are elderly and are at high-risk for surgery and those who are anatomically suitable, through the advances in graft technology.
Introduction
Abdominal aortic aneurysm (AAA) is present in 5-9% of males above 65 years [1, 2] . The incidence of AAA has increased in recent years and is currently estimated as 25-45/100,000/year [3] . The natural history of AAA shows a trend toward progressive enlargement and rupture [4] . It represents the 13th cause of death in the United States (0.8% of all deaths) [5, 6] . It can be treated by either open repair (OR) or endovascular aneurysm repair (EVAR). Endovascular techniques have developed rapidly within the last 20 years, and EVAR has developed as a viable noninvasive option for the elective treatment of patients with aneurysms. It offers a short-term benefit compared with OR for the management of large AAAs [7, 8] . Specifically, EVAR is less invasive than OR and is associated with significantly lower operative mortality [9] .
The aim of this study was to compare short-and middle-term outcomes with EVAR and OR in consecutive concurrent patients who were eligible for both techniques.
Materials and Methods
Our prospectively managed vascular registry revealed 46 consecutive patients who had elective and infrarenal AAA repair at our clinic between October 2012 and February 2014. Approval from the Institutional Review Board Ethics Committee was obtained for all aspects of this study. Written informed consent was obtained from all subjects. Twentyfour of the patients underwent EVAR, with bifurcated industry-made devices deployed with standard methods (polyester PTFE nitinol stent grafts). Open transperitoneal AAA repair was performed in 22 of the patients. We used bifurcated Dacron tube grafts for OR. During a six-month follow-up period, we conducted a prospective study to compare patient-perceived outcomes after elective infrarenal AAA repair. Collected information included pre-existent co-morbidities, cardiovascular risk factors (angiography was performed in high-risk patients) and aneurysm morphology, as well as in-hospital morbidity, mortality and length of stay. Identification of risk factors was based on previously published definitions [10] .
Indication for treatment of was a maximum transverse infrarenal aortic diameter of 55 mm or more. The expansion rate may be an important determinant of the risk of rupture [11] . A small AAA that expands 0.5 cm or more over 6 months of follow-up is considered to be at high risk for rupture [12] . Growth tends to be more rapid in smokers and less rapid in patients with diabetes mellitus or peripheral vascular disease [13] .
Endovascular repair was performed in patients with suitable anatomy who were considered high risk for open surgery based on surgeon's preference. Operative repair was performed via transperitoneal approach in all cases. The treating surgeons were able to perform both OR and EVAR. During the study period, 46 patients with AAAs had elective EVAR or OR. Of those, 24 EVAR and 22 OR patients were recruited into the study. The mean follow-up was 6 months. Patients' outcomes were analyzed according to type of repair. Perioperative mortality and morbidity included all events within 30 days of treatment or when the patient remained in the hospital. Collected events included surgical site infections and severe bleeding, as well as acute lower limb ischemia, blood transfusions and surgical revision during the same hospital stay.
Statistical analysis
Continuous variables were given as mean ± one standard deviation when normally distributed and as median when asymmetrically distributed. Categorical variables were presented as numbers. Differences between the continuous variables were compared with the two-tailed unpaired t-test if normally distributed and by the repeated measurements analysis of variance if asymmetrically distributed. The categorical variables were compared with the two-tailed Spearman's rho test. Chi-square tests, as appropriate, were used to compare nominal variables between the two groups. A P < 0.01 was considered to indicate statistical significance. All analyses were performed using a computerized software package, SPSS for windows, version 15.0 (SPSS, Chicago, IL, USA).
Results
Of the 46 patients with AAAs, 22 underwent elective OR (47.8%), and 24 patients received elective EVAR (52.2%). The mean age was lower in the elective OR (70.35 ± 6.16 years) group than in the EVAR group (72.18 ± 10.31 years; P < 0.05). All cases were performed under general anesthesia. The median operative and anesthesia times and estimated blood loss were all higher in the OR group. There was a statistically significant difference in the 30-day mortality rates between the groups (P < 0.01). There were no 30-day deaths in the EVAR group. One patient died after OR, yielding a 30-day mortality rate of 4%. The patients died from multiorgan failure and bleeding. The median hospital, postoperative, intensive care unit and intermediate care unit length of stay were all significantly shorter in the EVAR group (P < 0.01). The mean postoperative stay was 2.9 ± 0.3 days in the EVAR group compared with 11.5 ± 2 days in the OR group. The median time to the resumption of bowel function was also shorter in the EVAR group (P < 0.01).
We also compared the rates of individual cardiac complications in the two groups. These rates were all higher in the OR group compared with the EVAR group, without reaching statistical significance. The pulmonary complication rate was lower in the EVAR group (P < 0.05). There was no difference in renal or wound-related complications between the two groups. The graft-related complication rate was significantly higher in the EVAR group compared with the OR group. The proportion of patients with lower limb ischemia or stenosis requiring treatment within the 30-day postoperative period was higher in the EVAR group compared with the OR group (P < 0.05). The proportion of patients receiving blood products during the first 30-day postoperative period was significantly higher after OR compared to EVAR (median, OR: 7 U vs. EVAR: 1 U, P < 0.01). The median number of hospitalized days within the first 30 days was higher after OR (30 vs. 0 intra-operative exit us days, P < 0.01). Furthermore, repeat analysis excluding patients who were readmitted to the hospital after the initial hospitalization or excluding patients requiring reoperation did not change any of the outcomes (Table 1) .
Discussion
As the 13th leading cause of death in the United States, AAA is an important and costly health concern. Operative repair has mainly prevailed since its first use on March, 29, 1951 [14] . However, it still carries substantial morbidity and mortality, which are predominantly due to extensive operative trauma, changes in renal blood flow induced by aortic clamping, blood loss and ischemia-reperfusion injury to the lower part of the body and the intestines. Hence, OR is currently being challenged, with minimally invasive techniques such as EVAR that has become the treatment of choice for AAAs. Mortality and morbidity in elective procedures were found to be quite congruent for both modalities, with reported results depending on the respective study designs. Accepted 30-day mortality rates range around 3.8% for elective OR [15] and around 1.5% for elective EVAR [16] . Reported advantages of EVAR include lower perioperative morbidity and mortality, shorter hospital stay, lower blood loss and faster recovery [15] because EVAR is considerably less invasive than OR. On the other hand, EVAR is disadvantageous in terms of the need for continuous post-operative surveillance, a higher reintervention rate and endoleaks in up to 20% of patients [17] . Compared with OR, EVAR reduces operative mortality and aneurysm-related mortality over the medium term. A large number of studies have modeled risks for adverse outcomes following EVAR. These have failed to provide definitive evidence, but age, possibly gender, renal impairment, fitness and aneurysm size may be predictive of poorer 30-day survival. There may be a link between fitness for OR, aneurysm size and, possibly, device type and aneurysm-related mortality [18, 19] . In terms of all-cause mortality, pulmonary status, renal impairment and aneurysm size have been found to have a potential adverse effect on aneurysm-related mortality [20] . We found no evidence of consistent risk factors for reintervention. In relation to endoleaks, only age was a possible independent risk factor.
In this prospective study, we examined longitudinal changes in outcomes in elective EVAR and elective OR. At our institution, patients were selectively treated by EVAR if they were older, considered higher risk because of medical comorbidity or considered too frail to undergo OR. The possibility of reintervention, failure of the endograft and uncertainty about middle-term outcomes might adversely affect the patient. EVAR is a less invasive operative procedure, which is associated with a more favorable perioperative hospital course and a lower postoperative complication rate.
Conclusion
Endovascular repair is less invasive procedure with shorter perioperative hospital course and fewer postoperative complications. It may be an effective treatment of choice, with low mortality and morbidity rates for elderly patients at high-risk for OR and those who are anatomically suitable due to advances in graft technology. 
